About
Cyted are building a world where cancer is diagnosed earlier and faster.
We support healthcare professionals to make the best decisions for their patients.
Key Facts
Cyted is a gastrointestinal health company. We have delivered over 16,000 capsule sponge tests to patients at risk of oesophageal cancer and its precursor disease, Barrett’s oesophagus.
Additionally, more than 25,000 patient pathology samples have been processed and reported from our digital laboratory.
Successes in UK/NHS
National implementation pilots for capsule sponge managed pathway across NHS England and NHS Scotland. Digital pathology services (backlog reporting and telepathology) for NHS Acute Trusts throughout England.Company details
Solutions
Providing advanced screening and diagnostics
Specialism
Specialised diagnostics
Company details
Want to connect with this innovator?
Make an enquiryWebsite
cyted.aiFunding Status
Series A
Markets already exporting to
United Kingdom
Desired Markets
USA and Europe
Desired customer types
Hospitals, Pharma companies, CROs